Sign Up to like & get
recommendations!
1
Published in 2023 at "Clinical pharmacology in drug development"
DOI: 10.1002/cpdd.1237
Abstract: A novel dual delayed-release formulation (DR) of esomeprazole was developed to prolong the effect of esomeprazole inhibiting gastric acid secretion. This study investigated the effect of food on the pharmacokinetics (PK) and pharmacodynamics (PD) of…
read more here.
Keywords:
dual delayed;
effect;
delayed release;
food ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Drug design, development and therapy"
DOI: 10.2147/dddt.s392533
Abstract: Background Esomeprazole, a proton pump inhibitor (PPI), is widely used to treat acid-related disorders, but it has short plasma half-life which can cause insufficient gastric acid suppression, such as nocturnal acid breakthrough. A new dual…
read more here.
Keywords:
new dual;
dual delayed;
formulation;
delayed release ... See more keywords